IRAIDA ACOSTA VALLE: Open Payments
NPI 1558995464 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,505 in 130 payments from 27 companies in 2025. Trend: 2023 $1,983 · 2024 $1,849 · 2025 $2,505
Food & beverage: $2,488Education: $17
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 23 | $345 |
| AstraZeneca Pharmaceuticals LP | 13 | $298 |
| Novo Nordisk Inc | 13 | $208 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $206 |
| Novartis Pharmaceuticals Corporation | 10 | $196 |
| Lilly USA, LLC | 10 | $190 |
| ABBVIE INC. | 13 | $177 |
| Exact Sciences Corporation | 6 | $133 |
| SHIELD THERAPEUTICS INC | 1 | $104 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $92 |
Products named: Kerendia, OTEZLA, LEQVIO, FARXIGA, MOUNJARO, ACCRUFER, CREON, XIFAXAN.
Industry payments across FL — which companies pay providers there.
